Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)
CUSIP: 28658R106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 68,580,003
- Total 13F shares
- 49,901,732
- Share change
- +33,050,760
- Total reported value
- $354,801,793
- Price per share
- $7.11
- Number of holders
- 46
- Value change
- +$245,093,722
- Number of buys
- 40
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 28658R106?
CUSIP 28658R106 identifies CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28658R106:
Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AI ETI LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,009,400
|
$62,617,500 | — | 12 Aug 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
19%
|
13,150,849
|
$36,033,326 | — | 31 Mar 2024 | |
| Pontifax Management 4 G.P. (2015) Ltd. |
13D/G
|
Pontifax VI G.P. L.P. |
7.7%
|
5,206,380
|
$12,911,822 | $0 | 27 Jun 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
3.2%
|
2,193,742
|
$6,010,853 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
811,680
|
$2,224,003 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
310,486
|
$850,732 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.11%
|
78,276
|
$214,476 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
66,626
|
$182,616 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
55,223
|
$151,311 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
43,468
|
$119,103 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
30,440
|
$83,405 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.04%
|
29,466
|
$80,737 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
21,700
|
$59,458 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
20,106
|
$55,090 | — | 31 Mar 2024 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.02%
|
12,104
|
$45,390 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
10,617
|
$29,000 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
8,333
|
$21,665 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
5,925
|
$16,235 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,606
|
$9,880 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,709
|
$4,683 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
981
|
$2,688 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
50
|
$137 | — | 31 Mar 2024 | |
| Robert Azelby |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
500,000
|
— | — | 31 Oct 2022 | |
| Erin Lavelle |
3/4/5
|
COO & CFO |
—
class O/S missing
|
170,000
|
— | — | 31 Oct 2022 | |
| James B. Bucher |
3/4/5
|
EVP and General Counsel |
—
class O/S missing
|
95,000
|
— | — | 31 Oct 2022 | |
| Adam Joseph Rosenberg |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 26 Jun 2024 | |
| Leone D. Patterson |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 19 May 2022 | |
| Liam Ratcliffe |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 26 Jun 2024 | |
| Simon Tate |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 26 Jun 2024 |
Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2024
As of 30 Jun 2024,
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,901,732 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Samsara BioCapital, LLC, JANUS HENDERSON GROUP PLC, Boxer Capital, LLC, Affinity Asset Advisors, LLC, Driehaus Capital Management LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Ally Bridge Group (NY) LLC, and BlackRock Inc..
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
20
Q2 2024 holders
46
Holder diff
26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.